Skip to content
value.today

EarliTec Diagnostics, Inc.

🇺🇸 Decatur, Georgia, USAHealth CareFounded 2019
Total raised
$27 M
2 rounds on record
Latest round
$22 M
Mar 2024
First round on record
Feb 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of EarliTec Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$22 MNo. 2$10 to $50 million

EarliTec Diagnostics, Inc.: Raise no. 2, Mar 2024

Investors in this round

5 investors had bought by the notice of Apr 2, 2024: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $36 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Thomas V. Ressemann · Executive Officer, Director
  • James V. Adox · Director
  • Jim V. Grien · Director
  • Kurt V. Jacobus · Director
  • William V. Marks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas V. Ressemann, Ceo. Source: SEC Form D, newest notice filed Apr 2, 2024. Read the notice at the SEC.

equitySEC
Feb 2022$6 MNo. 1$2 to $10 million

EarliTec Diagnostics, Inc.: Raise no. 1, Feb 2022

Investors in this round

3 investors had bought by the notice of Feb 18, 2022: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $20 M offered; $14 M still to sell
Smallest investment taken
$55,807
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Thomas Ressemann · Executive Officer, Director
  • Jack Griffis · Director
  • Jacobus Kurt · Director
  • Jim Grien · Director
  • Jones Warren · Director · excludes normal compensation for officers and directors.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes normal compensation for officers and directors.”

Signed by Thomas Ressemann, President and CEO. Source: SEC Form D, newest notice filed Feb 18, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • EarliTec Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2024

That is all the official record says: EarliTec Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of EarliTec Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by EarliTec Diagnostics, Inc.
NameRoleNamed in
Thomas V. RessemannExecutive officerApr 2024
Thomas RessemannExecutive officerFeb 2022
James V. AdoxDirectorApr 2024
Jim V. GrienDirectorApr 2024
Kurt V. JacobusDirectorApr 2024
Thomas V. RessemannDirectorApr 2024
William V. MarksDirectorApr 2024
Jack GriffisDirectorFeb 2022
Jacobus KurtDirectorFeb 2022
Jim GrienDirectorFeb 2022
Jones Warrenexcludes normal compensation for officers and directors.Feb 2022
Thomas RessemannDirectorFeb 2022